DanGer Shock Trial Post-Hoc Analysis: Microaxial Pump Risks May Outweigh Benefits

In this post-hoc analysis of the DanGer Shock trial, patients in the highest quartile of age appeared to have higher mortality compared with younger patients, suggesting less benefit from routine application of the microaxial flow pump in older patients with acute myocardial infarction-related cardiogenic shock.